On Monday, Crescent Point Energy Corp (NYSE:CPG)’s shares declined -5.91% to $9.55.
Crescent Point Energy Corp. (CPG) confirms that the dividend to be paid on September 15, 2015, in respect of August 2015 production, for shareholders of record on August 31, 2015, will be CDN$0.10 per share.
These dividends are designated as “eligible dividends” for Canadian income tax purposes. For U.S. income tax purposes, Crescent Point’s dividends are considered “qualified dividends.”
Crescent Point’s shareholders will receive dividend payments in the form of cash.
Crescent Point Energy Corp. acquires, explores, develops, and produces oil and natural gas properties in Western Canada and the United States. The company’s oil and natural gas properties, and related assets are located in the provinces of Saskatchewan, Alberta, and Manitoba; and the states of North Dakota, Montana, Colorado, and Utah. Crescent Point Energy Corp. is headquartered in Calgary, Canada.
Coty Inc (NYSE:COTY)’s shares dropped -1.94% to $27.75.
Coty Inc. (COTY) declared that its Board of Directors has approved a $700 million share repurchase authorization of its Class A common stock. This authorization comprises any amounts remaining under the existing stock repurchase authorization.
Repurchases will be made from time to time at the Company’s discretion, based on ongoing assessments of the capital needs of the business, the market price of its common stock, and general market conditions. No time has been set for the completion of the repurchase program, and the program may be suspended or suspended at any time. The repurchase program authorizes the Company to purchase its common stock from time to time through open market purchases, negotiated transactions or other means, counting 10b5-1 trading plans in accordance with applicable securities laws and other restrictions.
Coty Inc., together with its auxiliaries, manufactures, markets, and distributes beauty products worldwide. The company operates through three segments: Fragrances, Color Cosmetics, and Skin & Body Care. The company offers fragrances under the Calvin Klein, Marc Jacobs, Davidoff, Chloé, Balenciaga, Beyoncé, Bottega Veneta, Guess?, Katy Perry, and Roberto Cavalli brand names. It also provides lip, eye, nail, and facial color products under the Bourjois, Rimmel, Sally Hansen, and OPI brands. In addition, the company offers shower gels, deodorants, skin care, and sun treatment products under the adidas, Lancaster, philosophy, and Playboy brand names.
At the end of Monday’s trade, SolarWinds Inc (NYSE:SWI)‘s shares dipped -1.58% to $38.57.
SolarWinds (NYSE: SWI), a leading provider of powerful and affordable hybrid IT infrastructure administration software, declared its participation at VMworld US 2015, August 30-September 3, 2015, in San Francisco. At the event, SolarWinds will exhibit its latest solutions for managing virtualized and hybrid IT environments, counting new capabilities to assist patch virtual systems. In addition, SolarWinds will host its second annual Experts & Espresso event, a series of free morning learning sessions, and Head Geek Thomas LaRock will present alongside VMware and Heraflux Technologies at two database virtualization breakout sessions.
SolarWinds, Inc., together with its auxiliaries, designs, develops, markets, sells, and supports enterprise-class information technology (IT) and infrastructure administration software to IT and DevOps professionals in various organizations worldwide. The company offers enterprise-class network administration products and tools that allow network administrators and other IT professionals to monitor and manage the performance and configuration of their network infrastructure, in addition to collect and analyze the log data for IT operations, security, and compliance administration.
Accuray Incorporated (NASDAQ:ARAY), ended its Monday’s trading session with -4.10% loss, and closed at $6.31.
Accuray Incorporated (ARAY) declared it has received a multi-system order from 21st Century Oncology for one CyberKnife® M6™ and four TomoHDA™ Systems. These are the latest generation CyberKnife and TomoTherapy Systems, and are used worldwide to provide extremely precise radiation treatments for cancerous and non-cancerous tumors throughout the body. The TomoTherapy Systems will replace conventional linear accelerators in single vault freestanding centers, reinforcing the TomoTherapy’s value as a mainstream radiation therapy device. Accuray booked the order in its first fiscal quarter of 2016.
Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, in addition to enables delivery of precise, high dose radiation while patients breathe normally.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
